Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
302 Ergebnisse
| JY3CT3 | Idexx Laboratories Inc./OS/Call [600]/JPMD | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 50,420 % | 0,253 | -0,027 | 12,605 | 21.08.2026 | 0,010 | JP Morgan | ||
| MJ3US6 |  | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 44,096 % | 0,430 | -0,014 | 5,651 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9JK7 | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 45,374 % | 0,535 | -0,010 | 3,598 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM4R4M | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | 650,000 | - | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MM5GLX | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 49,215 % | 0,334 | -0,022 | 8,619 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN088B | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | 650,000 | - | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MN506N | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 50,055 % | 0,591 | -0,009 | 2,708 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6E28 | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 43,759 % | 0,484 | -0,011 | 4,415 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MN8T9Y | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | 650,000 | - | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CDR | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | - | 54,407 % | 0,632 | -0,008 | 2,237 | 16.06.2028 | 0,010 | Morgan Stanley | |
| MR3SS6 | | Idexx Laboratories Inc./OS/Call [600]/MS | - | - | 600,000 | call | Idexx Laboratories Inc. | 650,000 | - | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| FA1BKP | Idexx Laboratories Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.09.2026 | 0,100 | Société Générale | ||
| FA1BKS | Idexx Laboratories Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.12.2026 | 0,100 | Société Générale | ||
| GW3QCC | Idexx Laboratories Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Idexx Laboratories Inc. | - | 41,772 % | 0,520 | -0,085 | 3,542 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW3QDK | Idexx Laboratories Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Idexx Laboratories Inc. | - | 41,975 % | 0,555 | -0,076 | 3,098 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW3QDR | Idexx Laboratories Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Idexx Laboratories Inc. | - | 41,043 % | 0,494 | -0,094 | 4,051 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW3RAF | Idexx Laboratories Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Idexx Laboratories Inc. | - | 42,999 % | 0,586 | -0,075 | 2,853 | 17.03.2028 | 0,100 | Goldman Sachs | ||
| GW4MN8 | Idexx Laboratories Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Idexx Laboratories Inc. | - | 43,156 % | 0,602 | -0,070 | 2,670 | 16.06.2028 | 0,100 | Goldman Sachs | ||
| GW00YR | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 41,696 % | 0,505 | -0,084 | 3,598 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW00YP | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 41,028 % | 0,503 | -0,096 | 4,007 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW011Q | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 41,988 % | 0,541 | -0,076 | 3,137 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW013Y | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 39,812 % | 0,429 | -0,103 | 5,036 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW014H | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 40,114 % | 0,385 | -0,115 | 5,950 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW3RAE | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 42,399 % | 0,557 | -0,073 | 2,965 | 17.03.2028 | 0,100 | Goldman Sachs | ||
| GW4MQ3 | Idexx Laboratories Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 42,536 % | 0,574 | -0,069 | 2,770 | 16.06.2028 | 0,100 | Goldman Sachs | ||
| JE9MGU | Idexx Laboratories Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 35,473 % | 0,334 | -0,011 | 7,533 | 18.12.2026 | 0,010 | JP Morgan | ||
| JY1LSF | Idexx Laboratories Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Idexx Laboratories Inc. | - | 37,590 % | 0,367 | -0,011 | 6,411 | 15.01.2027 | 0,010 | JP Morgan | ||
| FA1BKQ | Idexx Laboratories Inc./OS/Call [620]/SOC | - | - | 620,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.09.2026 | 0,100 | Société Générale | ||
| FA6T3X | Idexx Laboratories Inc./OS/Call [620]/SOC | - | - | 620,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.12.2026 | 0,100 | Société Générale | ||
| GJ4KUD | Idexx Laboratories Inc./OS/Call [625]/GOLDS | - | - | 625,000 | call | Idexx Laboratories Inc. | - | 40,355 % | 0,210 | -0,142 | 11,951 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW3QCB | Idexx Laboratories Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Idexx Laboratories Inc. | - | 40,917 % | 0,458 | -0,092 | 4,204 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW3QCA | Idexx Laboratories Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Idexx Laboratories Inc. | - | 42,358 % | 0,539 | -0,077 | 3,121 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW3QDJ | Idexx Laboratories Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Idexx Laboratories Inc. | - | 41,563 % | 0,490 | -0,084 | 3,657 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW3R7Y | Idexx Laboratories Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Idexx Laboratories Inc. | - | 42,248 % | 0,542 | -0,073 | 3,011 | 17.03.2028 | 0,100 | Goldman Sachs | ||
| GW4MQ4 | Idexx Laboratories Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Idexx Laboratories Inc. | - | 42,461 % | 0,562 | -0,069 | 2,804 | 16.06.2028 | 0,100 | Goldman Sachs | ||
| GW012C | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 40,576 % | 0,441 | -0,091 | 4,299 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GW012E | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 42,501 % | 0,526 | -0,077 | 3,149 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW012K | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 41,402 % | 0,478 | -0,083 | 3,709 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GW013T | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 39,516 % | 0,389 | -0,099 | 5,272 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW014C | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 39,533 % | 0,376 | -0,114 | 6,051 | 15.01.2027 | 0,100 | Goldman Sachs | ||
| GW3RCD | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 42,136 % | 0,530 | -0,073 | 3,052 | 17.03.2028 | 0,100 | Goldman Sachs | ||
| GW4MR9 | Idexx Laboratories Inc./OS/Call [640]/GOLDS | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 42,478 % | 0,552 | -0,069 | 2,830 | 16.06.2028 | 0,100 | Goldman Sachs | ||
| JE9MGV | Idexx Laboratories Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 35,565 % | 0,285 | -0,010 | 7,930 | 18.12.2026 | 0,010 | JP Morgan | ||
| JY006A | Idexx Laboratories Inc./OS/Call [640]/JPMD | - | - | 640,000 | call | Idexx Laboratories Inc. | - | 36,714 % | 0,320 | -0,010 | 6,874 | 15.01.2027 | 0,010 | JP Morgan | ||
| FA1BKR | Idexx Laboratories Inc./OS/Call [640]/SOC | - | - | 640,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.09.2026 | 0,100 | Société Générale | ||
| FA6T3Y | Idexx Laboratories Inc./OS/Call [640]/SOC | - | - | 640,000 | call | Idexx Laboratories Inc. | - | - | - | - | - | 18.12.2026 | 0,100 | Société Générale | ||
| GJ4KUB | Idexx Laboratories Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Idexx Laboratories Inc. | - | 40,556 % | 0,150 | -0,113 | 12,930 | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW3R7X | Idexx Laboratories Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Idexx Laboratories Inc. | - | 41,978 % | 0,518 | -0,072 | 3,092 | 17.03.2028 | 0,100 | Goldman Sachs | ||
| GW4MMS | Idexx Laboratories Inc./OS/Call [650]/GOLDS | - | - | 650,000 | call | Idexx Laboratories Inc. | - | 42,747 % | 0,551 | -0,070 | 2,819 | 16.06.2028 | 0,100 | Goldman Sachs | ||
| MK7437 | | Idexx Laboratories Inc./OS/Call [650]/MS | - | - | 650,000 | call | Idexx Laboratories Inc. | - | 43,777 % | 0,321 | -0,012 | 6,354 | 18.12.2026 | 0,010 | Morgan Stanley |